Exploiting sp(2) -Hybridisation in the Development of Potent 1,5-α-l-Arabinanase Inhibitors.
Identifieur interne : 004427 ( Ncbi/Merge ); précédent : 004426; suivant : 004428Exploiting sp(2) -Hybridisation in the Development of Potent 1,5-α-l-Arabinanase Inhibitors.
Auteurs : Travis Coyle [Australie] ; Aleksandra W. Debowski [Australie] ; Annabelle Varrot [France] ; Keith A. Stubbs [Australie]Source :
- Chembiochem : a European journal of chemical biology [ 1439-7633 ] ; 2017.
Descripteurs français
- KwdFr :
- MESH :
- antagonistes et inhibiteurs : Glycosidases.
- synthèse chimique : Antienzymes, Réactifs chromogènes.
- Cristallographie aux rayons X, Fusarium, Modèles moléculaires, Relation structure-activité.
English descriptors
- KwdEn :
- MESH :
- chemical , antagonists & inhibitors : Glycoside Hydrolases.
- chemical , chemical synthesis : Chromogenic Compounds, Enzyme Inhibitors.
- chemistry : Fusarium.
- Crystallography, X-Ray, Models, Molecular, Structure-Activity Relationship.
Abstract
The synthesis of potent inhibitors of GH93 arabinanases as well as a synthesis of a chromogenic substrate to measure GH93 arabinanase activity are described. An insight into the reasons behind the potency of the inhibitors was gained through X-ray crystallographic analysis of the arabinanase Arb93A from Fusarium graminearum. These compounds lay a foundation for future inhibitor development as well as for the use of the chromogenic substrate in biochemical studies of GH93 arabinanases.
DOI: 10.1002/cbic.201700073
PubMed: 28266777
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000B55
- to stream PubMed, to step Curation: 000B52
- to stream PubMed, to step Checkpoint: 000B52
Links to Exploration step
pubmed:28266777Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Exploiting sp(2) -Hybridisation in the Development of Potent 1,5-α-l-Arabinanase Inhibitors.</title>
<author><name sortKey="Coyle, Travis" sort="Coyle, Travis" uniqKey="Coyle T" first="Travis" last="Coyle">Travis Coyle</name>
<affiliation wicri:level="1"><nlm:affiliation>School of Molecular Sciences, University of Western Australia, 35 Stirling Highway, Crawley, WA, 6009, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>School of Molecular Sciences, University of Western Australia, 35 Stirling Highway, Crawley, WA, 6009</wicri:regionArea>
<wicri:noRegion>6009</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Debowski, Aleksandra W" sort="Debowski, Aleksandra W" uniqKey="Debowski A" first="Aleksandra W" last="Debowski">Aleksandra W. Debowski</name>
<affiliation wicri:level="1"><nlm:affiliation>School of Molecular Sciences, University of Western Australia, 35 Stirling Highway, Crawley, WA, 6009, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>School of Molecular Sciences, University of Western Australia, 35 Stirling Highway, Crawley, WA, 6009</wicri:regionArea>
<wicri:noRegion>6009</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Varrot, Annabelle" sort="Varrot, Annabelle" uniqKey="Varrot A" first="Annabelle" last="Varrot">Annabelle Varrot</name>
<affiliation wicri:level="4"><nlm:affiliation>CERMAV, Université Grenoble Alpes, CNRS, 38000, Grenoble, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>CERMAV, Université Grenoble Alpes, CNRS, 38000, Grenoble</wicri:regionArea>
<placeName><settlement type="city">Grenoble</settlement>
<region type="region" nuts="2">Auvergne-Rhône-Alpes</region>
<region type="old region" nuts="2">Rhône-Alpes</region>
<settlement type="city">Grenoble</settlement>
</placeName>
<orgName type="university">Université Grenoble-Alpes</orgName>
</affiliation>
</author>
<author><name sortKey="Stubbs, Keith A" sort="Stubbs, Keith A" uniqKey="Stubbs K" first="Keith A" last="Stubbs">Keith A. Stubbs</name>
<affiliation wicri:level="1"><nlm:affiliation>School of Molecular Sciences, University of Western Australia, 35 Stirling Highway, Crawley, WA, 6009, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>School of Molecular Sciences, University of Western Australia, 35 Stirling Highway, Crawley, WA, 6009</wicri:regionArea>
<wicri:noRegion>6009</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2017">2017</date>
<idno type="RBID">pubmed:28266777</idno>
<idno type="pmid">28266777</idno>
<idno type="doi">10.1002/cbic.201700073</idno>
<idno type="wicri:Area/PubMed/Corpus">000B55</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000B55</idno>
<idno type="wicri:Area/PubMed/Curation">000B52</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000B52</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000B52</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000B52</idno>
<idno type="wicri:Area/Ncbi/Merge">004427</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Exploiting sp(2) -Hybridisation in the Development of Potent 1,5-α-l-Arabinanase Inhibitors.</title>
<author><name sortKey="Coyle, Travis" sort="Coyle, Travis" uniqKey="Coyle T" first="Travis" last="Coyle">Travis Coyle</name>
<affiliation wicri:level="1"><nlm:affiliation>School of Molecular Sciences, University of Western Australia, 35 Stirling Highway, Crawley, WA, 6009, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>School of Molecular Sciences, University of Western Australia, 35 Stirling Highway, Crawley, WA, 6009</wicri:regionArea>
<wicri:noRegion>6009</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Debowski, Aleksandra W" sort="Debowski, Aleksandra W" uniqKey="Debowski A" first="Aleksandra W" last="Debowski">Aleksandra W. Debowski</name>
<affiliation wicri:level="1"><nlm:affiliation>School of Molecular Sciences, University of Western Australia, 35 Stirling Highway, Crawley, WA, 6009, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>School of Molecular Sciences, University of Western Australia, 35 Stirling Highway, Crawley, WA, 6009</wicri:regionArea>
<wicri:noRegion>6009</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Varrot, Annabelle" sort="Varrot, Annabelle" uniqKey="Varrot A" first="Annabelle" last="Varrot">Annabelle Varrot</name>
<affiliation wicri:level="4"><nlm:affiliation>CERMAV, Université Grenoble Alpes, CNRS, 38000, Grenoble, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>CERMAV, Université Grenoble Alpes, CNRS, 38000, Grenoble</wicri:regionArea>
<placeName><settlement type="city">Grenoble</settlement>
<region type="region" nuts="2">Auvergne-Rhône-Alpes</region>
<region type="old region" nuts="2">Rhône-Alpes</region>
<settlement type="city">Grenoble</settlement>
</placeName>
<orgName type="university">Université Grenoble-Alpes</orgName>
</affiliation>
</author>
<author><name sortKey="Stubbs, Keith A" sort="Stubbs, Keith A" uniqKey="Stubbs K" first="Keith A" last="Stubbs">Keith A. Stubbs</name>
<affiliation wicri:level="1"><nlm:affiliation>School of Molecular Sciences, University of Western Australia, 35 Stirling Highway, Crawley, WA, 6009, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>School of Molecular Sciences, University of Western Australia, 35 Stirling Highway, Crawley, WA, 6009</wicri:regionArea>
<wicri:noRegion>6009</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j">Chembiochem : a European journal of chemical biology</title>
<idno type="eISSN">1439-7633</idno>
<imprint><date when="2017" type="published">2017</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Chromogenic Compounds (chemical synthesis)</term>
<term>Crystallography, X-Ray</term>
<term>Enzyme Inhibitors (chemical synthesis)</term>
<term>Fusarium (chemistry)</term>
<term>Glycoside Hydrolases (antagonists & inhibitors)</term>
<term>Models, Molecular</term>
<term>Structure-Activity Relationship</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Antienzymes (synthèse chimique)</term>
<term>Cristallographie aux rayons X</term>
<term>Fusarium ()</term>
<term>Glycosidases (antagonistes et inhibiteurs)</term>
<term>Modèles moléculaires</term>
<term>Relation structure-activité</term>
<term>Réactifs chromogènes (synthèse chimique)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="antagonists & inhibitors" xml:lang="en"><term>Glycoside Hydrolases</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemical synthesis" xml:lang="en"><term>Chromogenic Compounds</term>
<term>Enzyme Inhibitors</term>
</keywords>
<keywords scheme="MESH" qualifier="antagonistes et inhibiteurs" xml:lang="fr"><term>Glycosidases</term>
</keywords>
<keywords scheme="MESH" qualifier="chemistry" xml:lang="en"><term>Fusarium</term>
</keywords>
<keywords scheme="MESH" qualifier="synthèse chimique" xml:lang="fr"><term>Antienzymes</term>
<term>Réactifs chromogènes</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Crystallography, X-Ray</term>
<term>Models, Molecular</term>
<term>Structure-Activity Relationship</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Cristallographie aux rayons X</term>
<term>Fusarium</term>
<term>Modèles moléculaires</term>
<term>Relation structure-activité</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The synthesis of potent inhibitors of GH93 arabinanases as well as a synthesis of a chromogenic substrate to measure GH93 arabinanase activity are described. An insight into the reasons behind the potency of the inhibitors was gained through X-ray crystallographic analysis of the arabinanase Arb93A from Fusarium graminearum. These compounds lay a foundation for future inhibitor development as well as for the use of the chromogenic substrate in biochemical studies of GH93 arabinanases.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">28266777</PMID>
<DateCreated><Year>2017</Year>
<Month>03</Month>
<Day>07</Day>
</DateCreated>
<DateCompleted><Year>2017</Year>
<Month>07</Month>
<Day>21</Day>
</DateCompleted>
<DateRevised><Year>2017</Year>
<Month>07</Month>
<Day>21</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1439-7633</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>18</Volume>
<Issue>11</Issue>
<PubDate><Year>2017</Year>
<Month>Jun</Month>
<Day>01</Day>
</PubDate>
</JournalIssue>
<Title>Chembiochem : a European journal of chemical biology</Title>
<ISOAbbreviation>Chembiochem</ISOAbbreviation>
</Journal>
<ArticleTitle>Exploiting sp(2) -Hybridisation in the Development of Potent 1,5-α-l-Arabinanase Inhibitors.</ArticleTitle>
<Pagination><MedlinePgn>974-978</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1002/cbic.201700073</ELocationID>
<Abstract><AbstractText>The synthesis of potent inhibitors of GH93 arabinanases as well as a synthesis of a chromogenic substrate to measure GH93 arabinanase activity are described. An insight into the reasons behind the potency of the inhibitors was gained through X-ray crystallographic analysis of the arabinanase Arb93A from Fusarium graminearum. These compounds lay a foundation for future inhibitor development as well as for the use of the chromogenic substrate in biochemical studies of GH93 arabinanases.</AbstractText>
<CopyrightInformation>© 2017 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Coyle</LastName>
<ForeName>Travis</ForeName>
<Initials>T</Initials>
<AffiliationInfo><Affiliation>School of Molecular Sciences, University of Western Australia, 35 Stirling Highway, Crawley, WA, 6009, Australia.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Present address: School of Chemistry, University College Dublin, Stillorgan Road, Belfield, Dublin, 4, Ireland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Debowski</LastName>
<ForeName>Aleksandra W</ForeName>
<Initials>AW</Initials>
<AffiliationInfo><Affiliation>School of Molecular Sciences, University of Western Australia, 35 Stirling Highway, Crawley, WA, 6009, Australia.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>School of Biomedical Sciences, University of Western Australia, 35 Stirling Highway, Crawley, WA, 6009, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Varrot</LastName>
<ForeName>Annabelle</ForeName>
<Initials>A</Initials>
<Identifier Source="ORCID">http://orcid.org/0000-0001-6667-8162</Identifier>
<AffiliationInfo><Affiliation>CERMAV, Université Grenoble Alpes, CNRS, 38000, Grenoble, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Stubbs</LastName>
<ForeName>Keith A</ForeName>
<Initials>KA</Initials>
<Identifier Source="ORCID">http://orcid.org/0000-0001-6899-402X</Identifier>
<AffiliationInfo><Affiliation>School of Molecular Sciences, University of Western Australia, 35 Stirling Highway, Crawley, WA, 6009, Australia.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2017</Year>
<Month>04</Month>
<Day>20</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>Germany</Country>
<MedlineTA>Chembiochem</MedlineTA>
<NlmUniqueID>100937360</NlmUniqueID>
<ISSNLinking>1439-4227</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D002863">Chromogenic Compounds</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D004791">Enzyme Inhibitors</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 3.2.1.-</RegistryNumber>
<NameOfSubstance UI="D006026">Glycoside Hydrolases</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 3.2.1.55</RegistryNumber>
<NameOfSubstance UI="C019713">alpha-N-arabinofuranosidase</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D002863" MajorTopicYN="N">Chromogenic Compounds</DescriptorName>
<QualifierName UI="Q000138" MajorTopicYN="N">chemical synthesis</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018360" MajorTopicYN="N">Crystallography, X-Ray</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004791" MajorTopicYN="N">Enzyme Inhibitors</DescriptorName>
<QualifierName UI="Q000138" MajorTopicYN="N">chemical synthesis</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005670" MajorTopicYN="N">Fusarium</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006026" MajorTopicYN="N">Glycoside Hydrolases</DescriptorName>
<QualifierName UI="Q000037" MajorTopicYN="Y">antagonists & inhibitors</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008958" MajorTopicYN="N">Models, Molecular</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013329" MajorTopicYN="N">Structure-Activity Relationship</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">arabinanases</Keyword>
<Keyword MajorTopicYN="N">carbamate</Keyword>
<Keyword MajorTopicYN="N">chromogenic substrate</Keyword>
<Keyword MajorTopicYN="N">enzyme inhibitors</Keyword>
<Keyword MajorTopicYN="N">hydroximolactone</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year>
<Month>02</Month>
<Day>14</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2017</Year>
<Month>3</Month>
<Day>8</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2017</Year>
<Month>7</Month>
<Day>22</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2017</Year>
<Month>3</Month>
<Day>8</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">28266777</ArticleId>
<ArticleId IdType="doi">10.1002/cbic.201700073</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Australie</li>
<li>France</li>
</country>
<region><li>Auvergne-Rhône-Alpes</li>
<li>Rhône-Alpes</li>
</region>
<settlement><li>Grenoble</li>
</settlement>
<orgName><li>Université Grenoble-Alpes</li>
</orgName>
</list>
<tree><country name="Australie"><noRegion><name sortKey="Coyle, Travis" sort="Coyle, Travis" uniqKey="Coyle T" first="Travis" last="Coyle">Travis Coyle</name>
</noRegion>
<name sortKey="Debowski, Aleksandra W" sort="Debowski, Aleksandra W" uniqKey="Debowski A" first="Aleksandra W" last="Debowski">Aleksandra W. Debowski</name>
<name sortKey="Stubbs, Keith A" sort="Stubbs, Keith A" uniqKey="Stubbs K" first="Keith A" last="Stubbs">Keith A. Stubbs</name>
</country>
<country name="France"><region name="Auvergne-Rhône-Alpes"><name sortKey="Varrot, Annabelle" sort="Varrot, Annabelle" uniqKey="Varrot A" first="Annabelle" last="Varrot">Annabelle Varrot</name>
</region>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004427 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 004427 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Asie |area= AustralieFrV1 |flux= Ncbi |étape= Merge |type= RBID |clé= pubmed:28266777 |texte= Exploiting sp(2) -Hybridisation in the Development of Potent 1,5-α-l-Arabinanase Inhibitors. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:28266777" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \ | NlmPubMed2Wicri -a AustralieFrV1
This area was generated with Dilib version V0.6.33. |